Tina Kader is an Endocrinology/Metabolic physician affiliated with University of Vermont. OpenAlex indexes 14 publications with 1,725 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.8%GLP-1 receptor agonist18%Ozempic51%Trulicity34%Mounjaro15%Part D<11 patientsInsulin Analog17.4%Tresiba Flextouch U-10016%Insulin Lispro16%Tresiba Flextouch U-20014%Novolog14%Novolog Flexpen12%Lantus Solostar11%Humalog Kwikpen U-10010%Toujeo Solostar8%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
28%l-Thyroxine20.6%Levothyroxine Sodium84%Synthroid16%Part D<11 patientsAntihypoglycemic Agent3.6%Baqsimi100%Part D≥20 patients+ 2 more classes in this area
Cardiovascular
5%Statin3.5%Atorvastatin Calcium100%Part D≥12 patientsCholesterol absorption inhibitor1.6%Ezetimibe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
The Lancet Diabetes & Endocrinology
2022 - Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
The Lancet Diabetes & Endocrinology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
David Krag, MD
University of Vermont
David Schneider, MD
University of Vermont
Robert Althoff, MD, PhD
University of Vermont
John Helzer, MD
University of Vermont
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”